Table 2.
Variables | Non-GC group (%) | GC group (%) |
---|---|---|
Number of subjects |
142 |
82 |
PG I (μg/L) |
|
|
≤30 |
2 (1.4) |
27 (32.9) |
≤40 |
2 (1.4) |
33 (40.2) |
≤50 |
9 (6.3) |
43 (52.4) |
≤60 |
19 (13.4) |
47 (57.3) |
≤70 |
25 (17.6) |
56 (68.2) |
≤80 |
33 (23.2) |
61 (74.3) |
≤90 |
41 (28.9) |
67 (81.7) |
>90 |
101 (71.1) |
15 (18.3) |
PG I/II radio |
|
|
≤3 |
2 (1.4) |
21 (25.6) |
≤4 |
7 (5.0) |
31 (37.8) |
≤5 |
18 (12.7) |
43 (52.4) |
≤6 |
25 (17.6) |
53 (64.6) |
≤7 |
33 (23.2) |
56 (68.3) |
≤8 |
38 (26.8) |
61 (74.4) |
≤9 |
49 (34.5) |
65 (80.4) |
>9 | 91(64.1) | 4 (4.7) |
Non-GC group included 55 of non-atrophic gastritis, 20 of atrophic gastritis, 36 of gastric ulcer, 31 of duodenal ulcer. GC group included 13 of early gastric cancer, 69 of advanced gastric cancer.